Lapsi Health, the Dutch-American healthtech company, and eMurmur, the Canadian-Austrian leader in cardiac and pulmonary auscultation AI, announced a partnership to integrate eMurmur's proven Heart AI algorithms into Keikku 2.0, the world's first FDA-cleared smart stethoscope with an integrated AI scribe. The collaboration sets a new standard for diagnostic accuracy and clinical efficiency. The integration combines eMurmur's clinically validated FDA-cleared and CE-marked

Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced primary results from the ASSURE® WCD Clinical Evaluation Post-Approval Study (ACE-PAS), presented as a late-breaking science session at the American Heart Association (AHA) Scientific Sessions 2025 in New Orleans. ACE-PAS, the largest prospective real-world study of wearable defibrillators to date, confirmed the strong safety and effectiveness of the ASSURE WCD in cl

Stereotaxis a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received U.S. Food and Drug Administration 510(k) clearance for its latest generation robotic system, GenesisX™. GenesisX is the latest advance in endovascular surgical robotics, building upon the established benefits of Robotic Magnetic Navigation while significantly enhancing the accessibility of the technology for healthcare providers.

Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will accelerate commercialization of the company’s first-generation Stentrode™ BCI platform, while advancing development of a frontier next-generation interface. The round was led by Double Point Ventures, alongside existing investors ARCH Ventures, Khosla Ventures, Bezos Expeditions, NTI and METIS. New investors

Aceso Interactive, Inc., a leading provider of patient engagement and healthcare communication technology, is pleased to announce a strategic partnership with Samsung Electronics America to deliver advanced interactive patient care and digital signage solutions to hospitals and health systems across North America. This collaboration brings together Samsung’s industry-leading display technology with Aceso’s enterprise-grade software platform to address the evolving needs

Xtant Medical Holdings, Inc., a global medical technology company focused on surgical solutions for the treatment of spinal, orthopedic, and wound care disorders, today announced the commercial launch of CollagenX™, its bovine collagen particulate product for surgical wound closure designed to promote healing, prevent dehiscence, and help mitigate concerns related to surgical site infections. CollagenX is a potential addition to every case type currently addressed by Xtant'

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that its LIBERTY® System, the first FDA cleared single-use, remotely operated robotic system for peripheral endovascular procedures, is now commercially available in the U.S. The Limited Market Release (LMR) will introduce LIBERTY® to selected high procedure volume regions where the Company already experienced preliminary demand for LIBERTY®. The LM

BD a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device Exemption (IDE) study, a prospective, multi-center study evaluating the Revello™ Vascular Covered Stent in patients with peripheral arterial disease (PAD). The announcement was made in conjunction with a late-breaking clinical trial presentation at the VIVA (Vascular InterVentional Advances) 2025 conference by Dr. Sean Lyden

Sovato, a company enabling healthcare organizations to implement and scale remote robotic surgery and procedure programs (also known as telesurgery), today announced the close of its Series B, bringing total funding to $41 million. Growth-stage venture capital firm Beringea led the round, with significant follow-on investments from existing investors. Notable participants include founding investor Polaris Partners, Intuitive, GS Ventures, Laerdal Million Lives Fund, Puma Venture Cap

MDIC Medical XR Summit – Snke OS GmbH has announced the unveiling of SnkeXR, the first medical grade, open platform AR glasses purpose-built for the medical technology industry. The product will be debuted November 4 and 5 at the Medical Device Innovation Consortium (MDIC) Medical Extended Reality (XR) Summit in Hyattsville, Md., with a keynote and simulated total hip arthroplasty (THA) from the main stage on November 4. “The power of augmented reality to bring accuracy,